Ryan MacDonald

May 14, 2026

Ryan MacDonald rated DOCS as Buy on May 14, 2026, setting a price target of 27. Shares have remained stable near 23.39, leaving the 27 target still in play.

May 12, 2026

On May 12, 2026, HIMS was given a Buy rating by Ryan MacDonald, with a target price of 35. The stock traded sideways with a -3.56% move, keeping the bullish thesis unresolved.

May 08, 2026

OMDA received a Buy rating from Ryan MacDonald on May 08, 2026, aiming for 28. Momentum has favored the Buy call, with shares climbing from 16.04 to 16.04, rewarding those who trusted the recommendation.

May 06, 2026

On May 06, 2026, Ryan MacDonald published a Buy outlook on HNGE, with a target of 63. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 54.06.

May 05, 2026

Ryan MacDonald on May 05, 2026 assigned DUOL a Buy rating, with a price target of 145. The recommendation remains pending validation as shares consolidate around 104.98.

Apr 30, 2026

On Apr 30, 2026, Ryan MacDonald reaffirmed WAY with a Buy rating, targeting 33. Shares slid 12.58% despite the recommendation, highlighting downside risks.

Apr 24, 2026

COUR was rated Buy by Ryan MacDonald on Apr 24, 2026, with a price objective of 10. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

Apr 22, 2026

On Apr 22, 2026, Ryan MacDonald initiated coverage on DCBO with a Buy rating and target of 31. The Buy call has yet to be validated as shares remain 14.32 away from the target.

Mar 31, 2026

Ryan MacDonald issued a Buy recommendation for PHR on Mar 31, 2026, price target set at 14. Investors following the Buy call captured upside momentum, with shares now at 9.19.

Mar 17, 2026

On Mar 17, 2026, DCGO was evaluated by Ryan MacDonald, who gave a Buy rating and target of 3. Investors saw limited payoff as shares fell short of the 3 target.

Mar 11, 2026

Ryan MacDonald rated TEM as Buy on Mar 11, 2026, setting a price target of 75. The stock has underperformed, dropping 12.87% despite the bullish target of 75.

Mar 05, 2026

VEEV received a Buy rating from Ryan MacDonald on Mar 05, 2026, aiming for 355. Price action was muted, as shares hovered around 155.73 despite the bullish outlook.

Feb 12, 2026

Ryan MacDonald on Feb 12, 2026 assigned MH a Buy rating, with a price target of 19. The call has struggled to gain traction, with shares losing 19.22%.

Oct 30, 2025

UDMY was rated Buy by Ryan MacDonald on Oct 30, 2025, with a price objective of 11. This case shows how bullish projections can fail, with the stock now below 4.63.

Sep 12, 2025

On Sep 12, 2025, Ryan MacDonald initiated coverage on CNC with a Buy rating and target of 39. The stock’s climb of 76.82% since the call highlights the foresight in the rating.

Aug 18, 2025

Ryan MacDonald issued a Buy recommendation for YEXT on Aug 18, 2025, price target set at 10. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

Mar 21, 2025

On Mar 21, 2025, PRVA was evaluated by Ryan MacDonald, who gave a Buy rating and target of 30. So far, the Buy call awaits clearer momentum, with shares flat at 22.63.

Feb 26, 2025

On Feb 26, 2025, Ryan MacDonald published a Buy outlook on ZETA, with a target of 43. Market action contradicted the Buy thesis, as shares slipped to 16.04.

Feb 21, 2025

Ryan MacDonald on Feb 21, 2025 assigned EVH a Buy rating, with a price target of 15. The call has struggled to gain traction, with shares losing 60.40%.

May 14, 2024

Ryan MacDonald rated PWSC as Buy on May 14, 2024, setting a price target of 26. The call has proven timely, with shares rising 24.51% toward the price target of 26.

May 08, 2024

On May 08, 2024, NRDY was given a Buy rating by Ryan MacDonald, with a target price of 4. Despite the Buy call, shares fell from 0.831 to 0.831, challenging the optimistic stance.

Apr 26, 2024

On Apr 26, 2024, Ryan MacDonald published a Buy outlook on LH, with a target of 255. Shares gained 28.24%, underscoring the accuracy of the bullish outlook toward 255.